These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27443837)

  • 1. Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy.
    Ogouyèmi-Hounto A; Damien G; Deme AB; Ndam NT; Assohou C; Tchonlin D; Mama A; Hounkpe VO; Moutouama JD; Remoué F; Ndiaye D; Gazard DK
    Parasite; 2016; 23():28. PubMed ID: 27443837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar.
    Win AA; Imwong M; Kyaw MP; Woodrow CJ; Chotivanich K; Hanboonkunupakarn B; Pukrittayakamee S
    Malar J; 2016 Feb; 15():110. PubMed ID: 26911145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012-2013.
    Dorkenoo AM; Yehadji D; Agbo YM; Layibo Y; Agbeko F; Adjeloh P; Yakpa K; Sossou E; Awokou F; Ringwald P
    Malar J; 2016 Jun; 15():331. PubMed ID: 27334876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy.
    Huang B; Deng C; Yang T; Xue L; Wang Q; Huang S; Su XZ; Liu Y; Zheng S; Guan Y; Xu Q; Zhou J; Yuan J; Bacar A; Abdallah KS; Attoumane R; Mliva AM; Zhong Y; Lu F; Song J
    Parasit Vectors; 2015 Dec; 8():634. PubMed ID: 26667053
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No polymorphisms in K13-propeller gene associated with artemisinin resistance in Plasmodium falciparum isolated from Brazzaville, Republic of Congo.
    Mayengue PI; Niama RF; Kouhounina Batsimba D; Malonga-Massanga A; Louzolo I; Loukabou Bongolo NC; Macosso L; Ibara Ottia R; Kimbassa Ngoma G; Dossou-Yovo LR; Pembet Singana B; Ahombo G; Sekangue Obili G; Kobawila SC; Parra HJ
    BMC Infect Dis; 2018 Oct; 18(1):538. PubMed ID: 30373565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013.
    Torrentino-Madamet M; Fall B; Benoit N; Camara C; Amalvict R; Fall M; Dionne P; Ba Fall K; Nakoulima A; Diatta B; Diemé Y; Ménard D; Wade B; Pradines B
    Malar J; 2014 Dec; 13():472. PubMed ID: 25471113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.
    Balikagala B; Mita T; Ikeda M; Sakurai M; Yatsushiro S; Takahashi N; Tachibana SI; Auma M; Ntege EH; Ito D; Takashima E; Palacpac NM; Egwang TG; Onen JO; Kataoka M; Kimura E; Horii T; Tsuboi T
    Malar J; 2017 Jan; 16(1):23. PubMed ID: 28068997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Benin.
    Ogouyèmi-Hounto A; Azandossessi C; Lawani S; Damien G; de Tove YS; Remoue F; Kinde Gazard D
    Malar J; 2016 Jan; 15():37. PubMed ID: 26801767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola.
    Plucinski MM; Talundzic E; Morton L; Dimbu PR; Macaia AP; Fortes F; Goldman I; Lucchi N; Stennies G; MacArthur JR; Udhayakumar V
    Antimicrob Agents Chemother; 2015 Jan; 59(1):437-43. PubMed ID: 25367912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin Resistance-Associated K13 Polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010-2015.
    Tacoli C; Gai PP; Bayingana C; Sifft K; Geus D; Ndoli J; Sendegeya A; Gahutu JB; Mockenhaupt FP
    Am J Trop Med Hyg; 2016 Nov; 95(5):1090-1093. PubMed ID: 27573632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
    Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
    Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children.
    Muwanguzi J; Henriques G; Sawa P; Bousema T; Sutherland CJ; Beshir KB
    Malar J; 2016 Jan; 15():36. PubMed ID: 26801909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Unique Plasmodium falciparum K13 Gene Mutation in Northwest Ethiopia.
    Bayih AG; Getnet G; Alemu A; Getie S; Mohon AN; Pillai DR
    Am J Trop Med Hyg; 2016 Jan; 94(1):132-5. PubMed ID: 26483118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC).
    Yobi DM; Kayiba NK; Mvumbi DM; Boreux R; Bontems S; Kabututu PZ; De Mol P; Speybroeck N; Mvumbi GL; Hayette MP
    PLoS One; 2020; 15(8):e0237791. PubMed ID: 32822392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Plasmodium falciparum k13 gene polymorphisms from Kisii County, Kenya during an era of artemisinin-based combination therapy deployment.
    Maniga JN; Samuel M; John O; Rael M; Muchiri JN; Bwogo P; Martin O; Sankarapandian V; Wilberforce M; Albert O; Onkoba SK; Adebayo IA; Adeyemo RO; Akinola SA
    Malar J; 2023 Mar; 22(1):87. PubMed ID: 36894982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.